BrainsWay Ltd. - PE Ratio
BRSYF
Price:
$16.84
Market Cap:
$583.16M
BrainsWay Ltd. is a global medical technology company focused on innovating and providing non-invasive neurostimulation therapies for a broad spectrum of mental health and neurological conditions. Operating across the United States, Europe, Israel, and other international markets, the company's core offering is its Deep Transcranial Magnetic Stimulation (dTMS) platform. This advanced technology is employed in the treatment of numerous disorders, including severe depression, anxious depression, obsessive-compulsive disorder, smoking addiction, bipolar disorders, post-traumatic stress disorder, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilita...[Read more]
Industry
Medical - Devices
IPO Date
2011-04-21
Stock Exchange
OTC
Ticker
BRSYF
PE Ratio
[76.55]
ROE
[12.28%]
Current Ratio
[3.34]
Dividend Yield
[0%]
Enterprise Value
[531.23M]
Dividend History
The PE Ratio as of June 2026 (TTM) for BrainsWay Ltd. (BRSYF) is 76.55
According to BrainsWay Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 76.55. This represents a change of 80.19% compared to the average of 42.48 of the last 4 quarters.
BrainsWay Ltd. (BRSYF) Historical PE Ratio (quarterly & annually)
How has BRSYF PE Ratio performed in the past?
The mean historical PE Ratio of BrainsWay Ltd. over the last ten years is -2.46. The current 76.55 PE Ratio has changed -311798.93% with respect to the historical average. Over the past ten years (40 quarters), BRSYF's PE Ratio was at its highest in in the December 2023 quarter at 210.76. The PE Ratio was at its lowest in in the September 2023 quarter at -72.40.
Average
-2.46
Median
-12.42
Minimum
-26.39
Maximum
53.26
BrainsWay Ltd. (BRSYF) PE Ratio by Quarter and Year
Discovering the peaks and valleys of BrainsWay Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 788.34%
Maximum Annual PE Ratio = 53.26
Minimum Annual Increase = -310.60%
Minimum Annual PE Ratio = -26.39
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 44.58 | -16.30% |
| 2024 | 53.26 | -310.60% |
| 2023 | -25.29 | 788.34% |
| 2022 | -2.85 | -84.63% |
| 2021 | -18.53 | 25.19% |
| 2020 | -14.80 | 52.30% |
| 2019 | -9.72 | -33.98% |
| 2018 | -14.72 | 45.56% |
| 2017 | -10.11 | -61.68% |
| 2016 | -26.39 | 23.32% |
BrainsWay Ltd. (BRSYF) Average PE Ratio
How has BRSYF PE Ratio performed in the past?
The current PE Ratio of BrainsWay Ltd. (BRSYF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
24.18
5-year avg
10.24
10-year avg
-2.46
BrainsWay Ltd. (BRSYF) PE Ratio vs. Peers
How is BRSYF’s PE Ratio compared to its peers?
BrainsWay Ltd.’s PE Ratio is less than CYBERDYNE Inc. (341.67), greater than M1 Kliniken AG (14.82), greater than BICO Group AB (publ) (-1.20), less than CYBERDYNE Inc. (341.67), greater than BICO Group AB (publ) (-1.20), greater than Medical Facilities Corporation (5.33), greater than Genfit S.A. (-6.20), greater than Santhera Pharmaceuticals Holding AG (-4.17), greater than Relevium Technologies Inc. (-0.33), greater than Paxman AB (publ) (-108.50),
| Company | PE Ratio | Market cap |
|---|---|---|
| 341.67 | $249.68M | |
| 14.82 | $214.81M | |
| -1.20 | $121.71M | |
| 341.67 | $248.85M | |
| -1.20 | $141.15M | |
| 5.33 | $222.89M | |
| -6.20 | $499.80M | |
| -4.17 | $344.83M | |
| -0.33 | $1.98M | |
| -108.50 | $149.87M |
Build a custom stock screener for BrainsWay Ltd. (BRSYF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BrainsWay Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BrainsWay Ltd. (BRSYF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BrainsWay Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is BrainsWay Ltd.'s PE Ratio?
How is the PE Ratio calculated for BrainsWay Ltd. (BRSYF)?
What is the highest PE Ratio for BrainsWay Ltd. (BRSYF)?
What is the 3-year average PE Ratio for BrainsWay Ltd. (BRSYF)?
What is the 5-year average PE Ratio for BrainsWay Ltd. (BRSYF)?
How does the current PE Ratio for BrainsWay Ltd. (BRSYF) compare to its historical average?